Klin Farmakol Farm. 2009;23(2):59-63

Treatment of acute heart failure

MUDr. Martin Hutyra Ph.D
I. interní klinika FN a LF UP Olomouc

Acute heart failure syndromes have emerged as a leading public health problem worldwide. Heterogeneity characterizes this group in terms

of mode of presentation, pathophysiology, and prognosis. The main classes of drugs used in pharmacotherapy are diuretics, vasodilators

and inotropic agents. Noninvasive ventilation appears to be of benefit in the immediate treatment of patients with acute cardiogenic pulmonary

edema and may reduce mortality. Some patients require cardiosurgical treatment or mechanical left ventricle assist device.

Keywords: acute heart failure syndrome, epidemiology, management, pharmacotherapy.

Published: July 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hutyra M. Treatment of acute heart failure. Klin Farmakol Farm. 2009;23(2):59-63.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Gheorghiade M, Zannad F, Sopko G, et al. Acute Heart Failure Syndromes: Current State and Framework for Future Research. Circulation. 2005; 112: 3958-3968. Go to original source... Go to PubMed...
    2. Gheorghiade M, Pang PS. Acute Heart Failure Syndromes. J Am Coll Cardiol 2009; 53: 557-573. Go to original source... Go to PubMed...
    3. Flaherty JD, Bax JJ, De Luca L, et al. Acute Heart Failure Syndromes in Patients With Coronary Artery Disease, Early Assessment and Treatment. J Am Coll Cardiol 2009; 53: 254-263. Go to original source... Go to PubMed...
    4. Špinar J, Špinarová L, Vítovec J. Diagnostika, epidemiologie a prognóza akutního srdečního selhání. Cor Vasa 2008; 50(4): 171-175. Go to original source...
    5. Špinar J, Janský P, Kettner J, et al. Doporučení pro diagnostiku a léčbu akutního srdečního selhání. Cor Vasa 2006; 48(1): Kardio 3-31.
    6. Ceriello A. Acute hyperglycaemia: a 'new' risk factor durig myocardial infarction. European Heart Journal 2005; 26: 328-331. Go to original source... Go to PubMed...
    7. Suleiman M, Hammerman H, Boulos M, et al. Fasting Glucose Is an Important Independent Risk Factor for 30-Day Mortality in Patients With Acute Myocardial Infarction: A Prospective Study. Circulation. 2005; 111: 754-760. Go to original source... Go to PubMed...
    8. Špinar J, Málek I. Léčba akutního srdečního selhání. Cor Vasa 2008; 50(4): 177-182. Go to original source...
    9. Gec DW. Acute Decompensated Heart Failure: The Shrinking Role of Inotropic Therapy. J Am Coll Cardiol, 2005; 46: 65-67. Go to original source... Go to PubMed...
    10. Gray A, Goodacre S, Newby DE, et al. Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema. N Engl J Med 2008; 359: 142-151. Go to original source... Go to PubMed...
    11. Thiele H, Smalling RW, Schuler GC. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. European Heart Journal 2007; 28: 2057-2063. Go to original source... Go to PubMed...
    12. Masip J, Roque M, Sánchez B, et al. Noninvasive ventilation in acute cardiogenic pulmonary oedema: systematic review and meta-analysis. JAMA 2005; 294: 3124-3130. Go to original source... Go to PubMed...
    13. Peter JV, Moran JL, Phillips-Hughes JK, et al. Effect of noninvasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet 2006; 367: 1155-1163. Go to original source... Go to PubMed...

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.